Skip to main content
Top
Published in: Malaria Journal 1/2014

Open Access 01-09-2014 | Oral presentation

Age-shifting in malaria incidence upon cessation of interventions: a simulation study

Authors: Peter Pemberton-Ross, Katya Galactionova, Tom Smith, Melissa Penny

Published in: Malaria Journal | Special Issue 1/2014

Login to get access

Excerpt

Malaria disease shifts to older ages when interventions are applied only to the youngest children, and incidence will resurge in endemic settings when intervention coverage decreases. This has consequences for the deployment of long-lasting insecticide treated nets or infection blocking vaccines (e.g. pre-erythrocytic vaccines). These delay acquisition of immunity, with the result that previously protected individuals may experience pathology later in life due to undeveloped or waning immunity. …
Metadata
Title
Age-shifting in malaria incidence upon cessation of interventions: a simulation study
Authors
Peter Pemberton-Ross
Katya Galactionova
Tom Smith
Melissa Penny
Publication date
01-09-2014
Publisher
BioMed Central
Published in
Malaria Journal / Issue Special Issue 1/2014
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-13-S1-O16

Other articles of this Special Issue 1/2014

Malaria Journal 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine